PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Bronchial thermoplasty shows long-term effectiveness for asthma

Data show improvements maintained for 5 years after procedure

2013-12-03
(Press-News.org) Contact information: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Bronchial thermoplasty shows long-term effectiveness for asthma Data show improvements maintained for 5 years after procedure DENVER – The beneficial effects of bronchial thermoplasty, a non-pharmacologic treatment for asthma, last at least five years, according to researchers at National Jewish Health and other institutions. The therapy, in which heat is applied to a patient's airways during a bronchoscopy procedure, was approved by the U.S. Food and Drug Administration in April 2010. Among other criteria, the researchers report in the December issue of the Journal of Allergy and Clinical Immunology that reductions in severe asthma exacerbations, emergency department visits, medication use and missed workdays continued out to five years after the procedure was performed. "These data add to the growing body of evidence that bronchial thermoplasty has a long-term benefit and is an important option for patients whose moderate to severe asthma is not controlled by medications," said Michael Wechsler, MD, lead author of the study and professor of medicine at National Jewish Health. During bronchial thermoplasty a physician uses a specialized bronchoscope to apply radio frequency energy to heat the airways. The treatment is done in three separate procedures approximately three weeks apart, and reduces smooth muscle surrounding the airways, which can constrict and reduce airflow in asthma. Earlier research showed that most patients who underwent bronchial thermoplasty in the AIR2 trial experienced benefits for at least two years. The current study extends that to five years. In the year before bronchial thermoplasty, 52 percent of patients suffered severe exacerbations of their asthma. That dropped to 31 percent in the first year following the treatment and averaged 29 percent over the five years following the procedure. After bronchial thermoplasty 78 percent fewer patients made visits to the emergency department, dropping from about 30 percent of patients to less than 7 percent. Missed workdays dropped 66 percent in the five years after bronchial thermoplasty. Average use of corticosteroid medications also dropped 17 percent. Stable rates of respiratory adverse events and respiratory-related hospitalizations as well as unchanged CT scans in years two through five indicated that there were no significant safety concerns with the procedure.

### END


ELSE PRESS RELEASES FROM THIS DATE:

Integrated pest managment techniques can help manage the Bagrada bug

2013-12-03
Integrated pest managment techniques can help manage the Bagrada bug The Bagrada bug, an invasive stink bug, was discovered in the western hemisphere in 2008 near Los Angeles, CA, presumably introduced via container shipments arriving at the Port of ...

A new weapon in the war against superbugs

2013-12-03
A new weapon in the war against superbugs Tel Aviv University researchers find a protein that viruses use to kill bacteria In the arms race between bacteria and modern medicine, bacteria have gained an edge. In recent decades, bacterial resistance to ...

Energy drinks plus alcohol pose a public health threat

2013-12-03
Energy drinks plus alcohol pose a public health threat ANN ARBOR—Mixing energy drinks with alcohol is riskier than just drinking alcohol alone, according to a new study that examines the impact of a growing trend among young adults. Published in the current issue ...

A living desert underground

2013-12-03
A living desert underground In the perpetual darkness of a limestone cave, UA researchers have discovered a surprisingly diverse ecosystem of microbes eking out a living from not much more than drip water, rock and air Hidden underneath the hilly grasslands studded ...

Ethnic identification helps Latina adolescents resist media barrage of body images

2013-12-03
Ethnic identification helps Latina adolescents resist media barrage of body images CORVALLIS, Ore. – A strong sense of ethnic identity can help Latina girls feel positive about their body and appearance, a new study concludes, even as this group ...

Aerobic fitness and hormones predict recognition memory in young adults

2013-12-03
Aerobic fitness and hormones predict recognition memory in young adults (Boston) – Researchers at Boston University School of Medicine (BUSM) have found further evidence that exercise may be beneficial for brain health and cognition. The findings, which ...

'Designer sperm' inserts custom genes into offspring

2013-12-03
'Designer sperm' inserts custom genes into offspring New research in The FASEB Journal suggests that altering genes in sperm and then inducing fertilization, produces new genes that are present and active in the embryos and inherited ...

Bothersome pain afflicts half of older Americans

2013-12-03
Bothersome pain afflicts half of older Americans Findings from a unique study underscore need for public health action on pain and disability in the elderly, reports PAIN® Philadelphia, December 2, 2013 – More than half of older adults in the United States – ...

Mission possible: Simulation-based training and experimentation on display

2013-12-03
Mission possible: Simulation-based training and experimentation on display A unique system that merges the virtual and real worlds to train Sailors for combat scenarios was unveiled Dec. 2 in Orlando. The Office of Naval Research (ONR) is demonstrating ...

NASA investigating the life of Comet ISON

2013-12-03
NASA investigating the life of Comet ISON After several days of continued observations, scientists continue to work to determine and to understand the fate of Comet ISON: There's no doubt that the comet shrank in size considerably as it rounded ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Bronchial thermoplasty shows long-term effectiveness for asthma
Data show improvements maintained for 5 years after procedure